KRRO

Korro Bio, Inc. - Common Stock (KRRO)

About Korro Bio, Inc. - Common Stock (KRRO)

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Details

Daily high

$11.94

Daily low

$9.50

Price at open

52 Week High

$55.89

52 Week Low

$5.20

Market cap

147.6M

Dividend yield

Volume

534

Avg. volume

167,725

P/E ratio

-1.00

Korro Bio, Inc. - Common Stock News